SENSEX NIFTY
73651.35 22326.9
655.04 (0.90%)
203.25 (0.92%)
 

NOTICES


Heading View
  SEBI Circular No. CIR/MRD/DP/01/2014 Dated 7th January, 2014   Click here
  SEBI Circular No. SEBI/HO/MIRSD/MIRSD2/CIR/P/2016/95, Dated 26th September, 2016.   Click here
DETACH
Increase
Minus
Hot Pursuit Back
Tatva Chintan Pharma makes a stellar listing
(29 Jul 2021, 10:13)
The scrip was listed at a price of Rs 2,111.80 per share, at a premium of 95% to the initial public offer (IPO) price. The stock has hit a high of 2,486.30 and a low of 2,111.80 so far. On the BSE, 3.19 lakh shares of the company were traded in the counter. The issue opened for bidding on Friday (16 July 2021) and closed on Tuesday (20 July 2021). The price band of the IPO was fixed at Rs 1073-1083 per share.

The initial public offer (IPO) of specialty chemicals manufacturing company Tatva Chintan Pharma Chem received bids for 58.83 crore shares as against 32.61 lakh shares on offer, according to stock exchange data. The issue was subscribed 180.36 times.

The non-institutional investors (NIIs) category was subscribed 512.22 times. The qualified institutional buyers (QIBs) category was subscribed 185.23 times. The retail individual investors (RIIs) category was subscribed 35.35 times.

The offer comprised of a fresh issue of equity shares aggregating to Rs 225 crore by the company and an offer for sale by selling shareholders aggregating to Rs 275 crore.

Ahead of the IPO, Tatva Chintan Pharma Chem on 15 July 2021 allotted 13,85,040 equity shares to 22 anchor investors, at Rs 1,083 per equity share, aggregating to Rs 149.99 crore.

The proceeds from the offer for sale shall be received by the selling shareholders. The company proposes to utilize the net proceeds of the fresh issue towards funding capital expenditure requirements for expansion of its Dahej manufacturing facility amounting Rs 147.1 crore, funding capital expenditure requirements for upgradation at its R&D facility in Vadodara amounting Rs 23.971 crore and balance towards general corporate purposes.

The company reported a consolidated net profit of Rs 52.26 crore and total income of Rs 300.36 crore in the twelve months ended 31 March 2021.

Tatva Chintan Pharma Chem is a specialty chemicals manufacturing company engaged in the manufacturing of a diverse portfolio of structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts for super capacitor batteries and pharmaceutical and agrochemical intermediates and other specialty chemicals (PASC). It is the largest and only commercial manufacturer of SDAs for zeolites in India.

Powered by Capital Market - Live News

 
Attention Investors: No need to issue cheques by investors while subscribing to IPO. just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account. | Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors.' "
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Dear Clients: We are here with requesting you to submit your separate e-mail id to receive communications/reports, by submitting account modification form in this regards or if you have registered your family member e-mail id with us, please submit declaration in this regards. Further, if you have not registered e-mail id/mobile number with us, please register it by submitting account modification form which facilitates you to receive all the data/reports electronically. If you require any clarification, please feel free to call Mr. Hemant Shah on 9004603818 or email us at kyc@swcapital.in
Feedback | Back Office | Downloads | KYC | Disclaimer | Privacy Policy | Investor Grievances | Communique | Tariff Structure |
SCORES| Opening A Account| Filing A Complaints
Copyright © 2011 -SW Capital Pvt Ltd. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)